Documents

Briefs, oral arguments, agency decisions and the Federal Register.

5,436 results

0.14s

  • Prescription Drug User Fee Act (PDUFA); Public Meeting

    Federal Register · Notice · Nov 19, 2001

    The Federal Food, Drug, and Cosmetic Act (the act) encourages FDA to consult with stakeholders, as appropriate, in carrying out agency responsibilities. … If you wish to make an oral presentation during the open public comment period of the meeting, you must specify on your registration you wish to make a presentation.

    66 FR 57967Health and Human Services DepartmentFood and Drug Administration
  • State Health Fraud Task Force Grants; Availability of Funds for Fiscal Year 2004: Request for Applications

    Federal Register · Notice · Jun 28, 2004

    An annual financial status report (FSR) is due 90 days after the end of each budget period. The final FSR is due 90 days after the end of the project period. … FDA does not guarantee that we will accommodate or explain SPOC comments that are received after the 60-day cutoff. B.

    69 FR 36091Health and Human Services DepartmentFood and Drug Administration
  • Hematology and Pathology Devices; Reclassification; Restricted Devices; OTC Test Sample Collection Systems for Drugs of Abuse Testing

    Federal Register · Rule · Apr 7, 2000

    One comment objected that OTC drugs of abuse test kits are not medical devices under section 201(h) of the act (21 U.S.C. 321(h)). … Fairness Act of 1996 (Public Law 104-121), and the Unfunded Mandates Reform Act of 1995 (Public Law 104-4).

    65 FR 18230Health and Human Services DepartmentFood and Drug Administration
  • Pediatric Studies of Sodium Nitroprusside Conducted in Accordance With the Public Health Service Act; Availability of Summary Report and Requested Labeling Changes

    Federal Register · Notice · Jan 24, 2014

    The Agency is making this information available consistent with the PHS Act. … The sodium nitroprusside docket remained opened for public comment from October 3, 2012, through November 2, 2012.

    79 FR 4167Health and Human Services DepartmentFood and Drug Administration
  • Investigational New Drug Applications and New Drug Applications

    Federal Register · Proposed Rule · Sep 8, 1995

    DATES: Written comments by December 7, 1995. … The General Accounting Office (GAO) conducted a larger study of drugs approved during the period 1988 through 1991, and found similar proportions.

    60 FR 46794Health and Human Services DepartmentFood and Drug Administration
  • Emergency Permit Control Regulations; Technical Amendments

    Federal Register · Proposed Rule · Sep 22, 2015

    For additional information on submitting comments, see the “Comments” heading of the SUPPLEMENTARY INFORMATION section of this document. … Additional Information Regarding Comments Interested persons may submit either electronic comments regarding this document to http://www.regulations.gov or written comments to the Division of Dockets

    80 FR 57137Health and Human Services DepartmentFood and Drug Administration
  • Advisory Committees; Notice of Meetings

    Federal Register · Uncategorized Document · Oct 18, 1994

    If necessary, comments may be limited to 5 minutes. Open committee discussion. … This notice is issued under section 10(a)(1) and (2) of the Federal Advisory Committee Act (5 U.S.C. app. 2), and FDA's regulations (21 CFR part 14) on advisory committees.

    Health and Human Services DepartmentFood and Drug Administration
  • Disqualification of a Clinical Investigator

    Federal Register · Proposed Rule · Apr 13, 2011

    Paperwork Reduction Act of 1995 X. Federalism XI. Request for Comments XII. References I. … It is only necessary to send one set of comments. It is no longer necessary to send two copies of mailed comments.

    76 FR 20575Health and Human Services DepartmentFood and Drug Administration
  • Irradiation in the Production, Processing, and Handling of Food

    Federal Register · Rule · Apr 13, 2011

    Objections and Requests for a Hearing Section 409(f)(1) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 348(f)(1)) provides that, within 30 days after publication of an order relating … The report was made available to the public for comment in the Federal Register of March 27, 1981 (46 FR 18992).

    76 FR 20509Health and Human Services DepartmentFood and Drug Administration
  • Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by New Plant Varieties Intended for Food Use

    Federal Register · Notice · Feb 10, 2006

    Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act … In the Federal Register of November 24, 2004 (69 FR 68381), FDA published a notice of availability with a 60-day comment period requesting public comment on the collection of information in FDA's draft

    71 FR 7048Health and Human Services DepartmentFood and Drug Administration
  • Requirements for Additional Traceability Records for Certain Foods: Compliance Date Extension

    Federal Register · Proposed Rule · Aug 7, 2025

    U.S.C. 601-612), and the Unfunded Mandates Reform Act of 1995 (Pub. … Effects of the Proposed Rule [Millions of 2024 dollars] Category Primary estimate Low estimate High estimate Units Year dollars Discount rate (%) Period

    90 FR 38084Health and Human Services DepartmentFood and Drug Administration
  • Over-the-Counter Drug Products Containing Colloidal Silver Ingredients or Silver Salts

    Federal Register · Proposed Rule · Oct 15, 1996

    DATES: Written comments by January 13, 1997; written comments on the agency's economic impact determination by January 13, 1997. … The agency is providing a period of 90 days from the date of publication of this proposed rule for comments on this subject to be developed and submitted.

    61 FR 53685Health and Human Services DepartmentFood and Drug Administration
  • Agency Information Collection Activities; Submission for OMB Review; Comment Request

    Federal Register · Notice · Mar 25, 1998

    DATES: Submit written comments on the collection of information by April 24, 1998. … The regulations contain no periodic reporting requirements.

    63 FR 14468Health and Human Services DepartmentFood and Drug Administration
  • Establishment Registration and Product Listing for Tobacco Products

    Federal Register · Proposed Rule · Jun 29, 2026

    DATES: Either electronic or written comments on the proposed rule must be submitted by September 14, 2026. ADDRESSES: You may submit comments as follows. … Please note that late, untimely filed comments will not be considered. The https://www.regulations.gov electronic filing system will accept comments until 11:59 p.m.

    91 FR 39168Health and Human Services DepartmentFood and Drug Administration
  • Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 058

    Federal Register · Notice · Aug 10, 2022

    Background Section 204 of the Food and Drug Administration Modernization Act of 1997 (Pub. L. 105-115) amended section 514 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 360d). … Such standards are those that FDA has recognized by notice published in the Federal Register or that FDA has decided to recognize but for which recognition is pending (because a periodic notice has

    87 FR 48671Health and Human Services DepartmentFood and Drug Administration
  • Institutional Review Boards: Requiring Sponsors and Investigators to Inform IRBs of Any Prior IRB Reviews

    Federal Register · Proposed Rule · Mar 6, 2002

    Introduction IRBs are boards, committees, or other groups formally designated by an institution to review, approve the initiation of, and conduct periodic review of biomedical research involving human … (While section 520(g) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360j(g)) refers to “institutional review committees” rather than IRBs, FDA considers institutional review committees to be IRBs

    67 FR 10115Health and Human Services DepartmentFood and Drug Administration
  • Over-The-Counter Human Drugs; Labeling Requirements; Final Rule; Technical Amendment

    Federal Register · Rule · Jan 3, 2000

    Submit written comments by March 18, 2000. … Therefore, under the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and under authority delegated to the Commissioner of Food and Drugs, 21 CFR parts 201, 341, and 369 are amended

    65 FR 7Health and Human Services DepartmentFood and Drug Administration
  • Exocrine Pancreatic Insufficiency Drug Products for Over-The- Counter Human Use

    Federal Register · Rule · Apr 24, 1995

    Interested persons were invited to submit comments by April 21, 1980. Reply comments in response to comments filed in the initial comment period could be submitted by May 21, 1980. … (the act) (21 U.S.C. 321(p)).

    60 FR 20162Health and Human Services DepartmentFood and Drug Administration
  • Recordkeeping Requirements for Human Food and Cosmetics Manufactured From, Processed With, or Otherwise Containing, Material From Cattle

    Federal Register · Proposed Rule · Jul 14, 2004

    We seek comments on this interpretation. … FDA invites public comment on this proposed rule. The agency will consider modifications to this proposed rule based on comments made during the comment period.

    69 FR 42275Health and Human Services DepartmentFood and Drug Administration
  • FDA Regulation of Combination Products; Public Hearing

    Federal Register · Notice · Oct 28, 2002

    If you wish to make an oral presentation during the open public comment period of the hearing, you must state your intention on your registration form or with the registration contact person listed ( … In accordance with section 503(g)(1) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 353(g)(l)), the agency is required to assign premarket review responsibility for combination products

    67 FR 65801Health and Human Services DepartmentFood and Drug Administration

Ask Donna what matters in the record.

She can read the source against your case and show you exactly where the answer came from.

Ask Donna

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.